Abstract

Cytisine, a natural product with high affinity for clinically relevant nicotinic acetylcholine receptors (nAChRs), is used as a smoking-cessation agent. The compound displays an excellent clinical profile and hence there is an interest in derivatives that may be further improved or find use in the treatment of other conditions. Here, the binding of a cytisine derivative modified by the addition of a 3-(hydroxypropyl) moiety (ligand 4) to Aplysia californica acetylcholine-binding protein (AcAChBP), a surrogate for nAChR orthosteric binding sites, was investigated. Isothermal titration calorimetry revealed that the favorable binding of cytisine and its derivative to AcAChBP is driven by the enthalpic contribution, which dominates an unfavorable entropic component. Although ligand 4 had a less unfavorable entropic contribution compared with cytisine, the affinity for AcAChBP was significantly diminished owing to the magnitude of the reduction in the enthalpic component. The high-resolution crystal structure of the AcAChBP-4 complex indicated close similarities in the protein-ligand interactions involving the parts of 4 common to cytisine. The point of difference, the 3-(hydroxypropyl) substituent, appears to influence the conformation of the Met133 side chain and helps to form an ordered solvent structure at the edge of the orthosteric binding site.

Highlights

  • Nicotine (1; Fig. 1) is the archetypical ligand of nicotinic acetylcholine receptors, a family of excitatory pentameric ligand-gated ion channels that contribute to the function of the human peripheral and central nervous system

  • Cytisine (2; Fig. 1) is a natural product widely distributed in Cytisus and Laburnum species and is the active component in the smoking-cessation agent called Tabex, which is used widely in Central and Eastern Europe

  • We have characterized the binding of cytisine and ligand 4, a novel 9-substitued cytisine variant, to Aplysia californica acetylcholinebinding protein (AcAChBP) using Isothermal titration calorimetry (ITC) and reported the high-resolution crystal structure of the AcAChBP–4 complex

Read more

Summary

Introduction

Nicotine (1; Fig. 1) is the archetypical ligand of nicotinic acetylcholine receptors (nAChRs), a family of excitatory pentameric ligand-gated ion channels (pLGICs) that contribute to the function of the human peripheral and central nervous system. This family of receptors is being studied as they may represent therapeutic targets for Alzheimer’s disease, Parkinson’s disease and anti-nociception (Quik & Wonnacott, 2011; Umana et al, 2013; Lombardo & Maskos, 2015). Nicotine is notorious as the agent responsible for the addictive effects of tobacco smoking, which worldwide is estimated to have caused six million deaths and 150 million disability-adjusted life years in 2015, and these numbers are increasing (GBD 2015 Tobacco Collaborators, 2017).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call